文献速递肝病消化道肿瘤与早癌

系统综述与荟萃分析:减重手术降低肝细胞癌发生率

Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma.
PubMed 文献 · Aliment Pharmacol Ther · 2021-03-15

结果显示减重手术与HCC风险降低相关,未调整OR为0.40(95%CI 0.28-0.57),匹配队列调整模型OR为0.63(95%CI 0.53-0.75),发生率比值为0.28(95%CI 0.18-0.42)。

要点

  • 减重手术与肝细胞癌发生风险降低相关,调整模型OR为0.63(95%CI 0.53-0.75)。
  • 减重手术患者HCC发生率为0.05/1000人年,对照组为0.34/1000人年。
  • 发生率比值为0.28(95%CI 0.18-0.42),支持减重手术降低HCC风险。

核心结论

  • 减重手术与肝细胞癌发生风险降低相关。

主要发现

  • 汇总未调整OR为0.40(95%CI 0.28-0.57),支持减重手术,但异质性高(I2=79%)。
  • 基于匹配队列的调整模型(5项研究)得出OR为0.63(95%CI 0.53-0.75),异质性中等(I2=38%)。
  • 减重手术患者汇总发生率为0.05/1000人年(95%CI 0.02-0.07),对照组为0.34/1000人年(95%CI 0.20-0.49),发生率比值为0.28(95%CI 0.18-0.42)。

临床怎么用

  • 对于肥胖伴非酒精性脂肪性肝炎(NASH)等HCC风险升高的患者,减重手术可能作为降低HCC风险的策略之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is a risk factor for non-alcoholic steatohepatitis (NASH) and increases the risk of several cancer types including cancers of the liver. Bariatric surgery can provide durable weight loss, but little is known about the later development of hepatocellular carcinoma (HCC) after surgery. AIM: To determine whether bariatric surgery reduces the risk of HCC. METHODS: We performed a comprehensive literature search of major databases (from inception to November 2020) to identify studies which assess the incidence and risk of HCC following bariatric surgery. Pooled data were assessed using a random-effects model expressed in terms of odds ratio (OR), incidence rate ratio and 95% confidence interval (CI). RESULTS: Nine studies (two abstracts and seven full texts) were included for meta-analysis which involved 19 514 750 patients (18 423 546 controls and 1 091 204 bariatric patients). Pooled unadjusted odds ratio (OR) was 0.40 (95% CI: 0.28-0.57) which favoured bariatric surgery, though with high heterogeneity (I2 : 79%). Using an adjusted model derived from matched cohorts (five studies) yielded an OR of 0.63 (95% CI: 0.53-0.75) with moderate heterogeneity (I2 : 38%). The pooled rate/1000 person-years was 0.05 (95% CI: 0.02-0.07) in bariatric surgery patients and 0.34 (95% CI: 0.20-0.49) in the control group with an incidence rate ratio of 0.28 (95% CI: 0.18-0.42). CONCLUSION: Bariatric surgery is associated with a decreased risk of HCC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ramai D, Singh J, Lester J, et al. Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma. Aliment Pharmacol Ther. 2021. PMID: 33721336. doi:10.1111/apt.16335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。